Tenaya and Lucerne: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-And-Extend Dosing in Year 2

AuthID
P-013-TKZ
100
Author(s)
Khanani A.M.
·
Kotecha A.
·
Chang A.
·
Chen S.J.
·
Chen Y.
·
Guymer R.
·
Heier J.S.
·
Holz F.G.
·
Iida T.
·
Ives J.A.
·
[+46]·
[+34]·
Figueroa M.
·
Fine H.
·
Fineman M.
·
Fox G.M.
·
Francais C.
·
Franco P.
·
Fraser-Bell S.
·
Fung N.
·
Sola F.F.
Tipo de Documento
Article
Year published
2024
Publicado
in Ophthalmology, ISSN: 01616420
Volume: 131, Número: 8, Páginas: 914-926 (12)
Indexing
Publication Identifiers
Pubmed: 38382813
SCOPUS: 2-s2.0-85187901367
Source Identifiers
ISSN: 01616420
Export Publication Metadata
Citações
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.



CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Info
At this moment we don't have any links to full text documens.
Name Order Nome   Name Order Nome   Name Order Nome
1 Khanani A.M.;   2 Kotecha A.;   3 Chang A.;
4 Chen S.J.;   5 Chen Y.;   6 Guymer R.;
7 Heier J.S.;   8 Holz F.G.;   9 Iida T.;
10 Ives J.A.;   11 Lim J.I.;   12 Lin H.;
13 Michels S.;   14 Quezada Ruiz C.;   15 Schmidt-Erfurth U.;
16 Silverman D.;   17 Singh R.;   18 Swaminathan B.;
19 Willis J.R.;   20 Tadayoni R.;   21 Abbey A.;
22 Abdulaeva E.;   23 Abraham P.;   24 Adan Civera A.;
25 Agostini H.;   26 Alezzandrini A.;   27 Alfaro V.;
28 Almony A.;   29 Altay L.;   30 Amini P.;
31 Antoszyk A.;   32 Aradi E.;   33 Arias L.;
34 Arnold J.;   35 Asaria R.;   36 Astakhov S.;
37 Astakhov Y.;   38 Awh C.C.;   39 Balaratnasingam C.;
40 Banerjee S.;   41 Baumal C.;   42 Becker M.;
43 Belfort R.;   44 Bratko G.;   45 Bridges W.Z.;
46 Brown J.;   47 Brown D.M.;   48 Budzinskaya M.;
49 Buffet S.;   50 Burgess S.;   51 Byon I.;
52 Cagini C.;   53 Calzada J.;   54 Cameron S.;
55 Campochiaro P.;   56 Carlson J.;   57 Carneiro A. ;
58 Chan C.;   59 Chang E.;   60 Chao D.;
61 Chaudhry N.;   62 Chee C.;   63 Cheek A.;
64 Chen S.N.;   65 Cheung G.;   66 Chexal S.;
67 Chittum M.;   68 Chow D.;   69 Cole A.;
70 Connolly B.;   71 Cornut P.L.;   72 Couvillion S.;
73 Danzig C.;   74 Daskalov V.;   75 Dessouki A.;
76 Devin F.;   77 Dollin M.;   78 Dolz R.;
79 Downey L.;   80 Dreyer R.;   81 Dugel P.;
82 Eichenbaum D.;   83 Eldem B.;   84 Engstrom R.;
85 Escobar J.J.;   86 Eter N.;   87 Faber D.W.;
88 Falk N.;   89 Feiner L.;   90 Vega A.F.;
91 Ferrone P.;   92 Figueroa M.;   93 Fine H.;
94 Fineman M.;   95 Fox G.M.;   96 Francais C.;
97 Franco P.;   98 Fraser-Bell S.;   99 Fung N.;
100 Sola F.F.;